Publication | Closed Access
Pharmacokinetics of liposomal daunorubicin (DaunoXome) during a phase I-II study in children with relapsed acute lymphoblastic leukaemia
65
Citations
0
References
2000
Year
Hematological MalignancyPediatric HematologyMedicineMixed-phenotype Acute LeukemiaPhase I-ii StudyHematologyPharmacologyPharmacotherapyLiposomal DaunorubicinOncologyMyeloid Neoplasia
No additional data available for this publication yet. Check back later!